Literature DB >> 17612591

Therapeutic effect of microencapsulated porcine retinal pigmented epithelial cells transplantation on rat model of Parkinson's disease.

Hou-Liang Zhang1, Jian-Jun Wu, Hui-Min Ren, Jian Wang, Ya-Ru Su, Yu-Ping Jiang.   

Abstract

OBJECT: To investigate the therapeutic effect of microencapsulated porcine retinal pigmented epithelial cells (RPE-M) transplantation on rat model of Parkinson's disease (PD).
METHODS: Primary porcine RPE cells were harvested by enzyme digestion and expanded in culture medium. Determine the levels of dopamine (DA) and homovanillic acid (HVA) by high performance liquid chromatography electrochemical (HPLC) assay, and the levels of brain-derived neurotrophic factor (BDNF) and glial-derived neurotrophic factor (GDNF) were detected by ELISA. Alginate-polylysine-alginate (APA) microencapsulated cells were produced by using a high voltage electrostatic system. PD rat model was established by unilateral injection of 6-hydroxydopamine (6-OHDA) into the medial forebrain bundle (MFB). After that, the RPE-M was transplanted into the corpus striatum of PD rat, and then the rotation test scores were recorded and biochemical changes of the corpus striatum were tested.
RESULTS: The levels of DA, HVA, BDNF and GDNF secreted by RPE were stable in the RPE culture supernatant and were not changed by the microencapsulation. Eighty-three percent rats developed PD by unilateral lesion of 6-OHDA in the MFB. The RPE-M transplantation had therapeutic effect on 33% PD rats.
CONCLUSION: Porcine RPE cells grow actively in vitro and could secrete DA, HVA, BDNF, and GDNF constantly, which does not be affected by the passage culture and the APA miroencapsulation. RPE-M transplantation of may be a curative therapy for PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17612591      PMCID: PMC5550627          DOI: 10.1007/s12264-007-0020-3

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  11 in total

1.  Reduction of p66Shc suppresses oxidative damage in retinal pigmented epithelial cells and retina.

Authors:  Zhihao Wu; Brian Rogers; Shu Kachi; Sean F Hackett; Anna Sick; Peter A Campochiaro
Journal:  J Cell Physiol       Date:  2006-12       Impact factor: 6.384

2.  Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease.

Authors:  Natividad P Stover; Roy A E Bakay; Thyagarajan Subramanian; Cathy D Raiser; Michael L Cornfeldt; Alfred W Schweikert; Richard C Allen; Ray L Watts
Journal:  Arch Neurol       Date:  2005-12

3.  Expression of tyrosinase and the tyrosinase related proteins in the Mitfvit (vitiligo) mouse eye: implications for the function of the microphthalmia transcription factor.

Authors:  S B Smith; B K Zhou; S J Orlow
Journal:  Exp Eye Res       Date:  1998-04       Impact factor: 3.467

4.  Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.

Authors:  Hong Yuan; Sophie Sarre; Guy Ebinger; Yvette Michotte
Journal:  J Neurosci Methods       Date:  2004-12-08       Impact factor: 2.390

Review 5.  Cell transplantation for the treatment of Parkinson's disease.

Authors:  T Subramanian
Journal:  Semin Neurol       Date:  2001       Impact factor: 3.420

6.  Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells.

Authors:  S A Vinores; J D Henderer; J Mahlow; C Chiu; N L Derevjanik; W Larochelle; C Csaky; P A Campochiaro
Journal:  Exp Eye Res       Date:  1995-06       Impact factor: 3.467

7.  Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression.

Authors:  Y Sun; X Ma; D Zhou; I Vacek; A M Sun
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

8.  Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response.

Authors:  Thyagarajan Subramanian; Deanna Marchionini; Elizabeth M Potter; Michael L Cornfeldt
Journal:  Cell Transplant       Date:  2002       Impact factor: 4.064

9.  Transdifferentiation of bioencapsulated bone marrow cells into hepatocyte-like cells in the 90% hepatectomized rat model.

Authors:  Zun Chang Liu; Thomas Ming Swi Chang
Journal:  Liver Transpl       Date:  2006-04       Impact factor: 5.799

10.  Rapid and sensitive determination of catecholamines and the metabolite 3-methoxy-4-hydroxyphen-ethyleneglycol using HPLC following novel extraction procedures.

Authors:  E Hollenbach; C Schulz; H Lehnert
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

View more
  8 in total

1.  Intrastriatal transplantation of retinal pigment epithelial cells for the treatment of Parkinson disease: in vivo longitudinal molecular imaging with 18F-P3BZA PET/CT.

Authors:  Lihong Bu; Renfei Li; Hongguang Liu; Wei Feng; Xiaoxing Xiong; Heng Zhao; Douglas Vollrath; Baozhong Shen; Zhen Cheng
Journal:  Radiology       Date:  2014-04-20       Impact factor: 11.105

2.  Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat.

Authors:  Amanda-Jayne Carr; Anthony A Vugler; Sherry T Hikita; Jean M Lawrence; Carlos Gias; Li Li Chen; David E Buchholz; Ahmad Ahmado; Ma'ayan Semo; Matthew J K Smart; Shazeen Hasan; Lyndon da Cruz; Lincoln V Johnson; Dennis O Clegg; Pete J Coffey
Journal:  PLoS One       Date:  2009-12-03       Impact factor: 3.240

3.  Intrastriatal transplantation of GDNF-engineered BMSCs and its neuroprotection in lactacystin-induced Parkinsonian rat model.

Authors:  Jianjun Wu; Wenbo Yu; Yan Chen; Yaru Su; Zhengtong Ding; Huimin Ren; Yuping Jiang; Jian Wang
Journal:  Neurochem Res       Date:  2009-11-06       Impact factor: 3.996

4.  Triptolide protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats: implication for immunosuppressive therapy in Parkinson's disease.

Authors:  Jun-Peng Gao; Shan Sun; Wen-Wei Li; Yi-Ping Chen; Ding-Fang Cai
Journal:  Neurosci Bull       Date:  2008-06       Impact factor: 5.203

Review 5.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

6.  Effects of passage and cryopreservation on neurotrophic factor secretion from choroid plexus epithelial cells.

Authors:  Feng Zhao; Xiao-Yan Ding; Feng Wu; Xiao-Hui Li; Yu-Huan Li; Sheng-Li Huang
Journal:  Biomed Rep       Date:  2018-04-19

7.  Adult human olfactory epithelial-derived progenitors: a potential autologous source for cell-based treatment for Parkinson's disease.

Authors:  Meng Wang; Chengliang Lu; Fred Roisen
Journal:  Stem Cells Transl Med       Date:  2012-06-01       Impact factor: 6.940

8.  Interphotoreceptor matrix-poly(ϵ-caprolactone) composite scaffolds for human photoreceptor differentiation.

Authors:  Petr Baranov; Andrew Michaelson; Joydip Kundu; Rebecca L Carrier; Michael Young
Journal:  J Tissue Eng       Date:  2014-10-01       Impact factor: 7.813

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.